73 related articles for article (PubMed ID: 37660340)
1. Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma.
Kongpetch S; Jusakul A; Lim JQ; Ng CCY; Chan JY; Rajasegaran V; Lim TH; Lim KH; Choo SP; Dima S; Popescu I; Duda DG; Kukongviriyapan V; Khuntikeo N; Pairojkul C; Rozen SG; Tan P; Teh BT
JCO Glob Oncol; 2020 Apr; 6():628-638. PubMed ID: 32315234
[TBL] [Abstract][Full Text] [Related]
2. Current Perspectives on Opisthorchiasis Control and Cholangiocarcinoma Detection in Southeast Asia.
Khuntikeo N; Titapun A; Loilome W; Yongvanit P; Thinkhamrop B; Chamadol N; Boonmars T; Nethanomsak T; Andrews RH; Petney TN; Sithithaworn P
Front Med (Lausanne); 2018; 5():117. PubMed ID: 29765958
[TBL] [Abstract][Full Text] [Related]
3. Spatio-Temporal Analysis of Cholangiocarcinoma in a High Prevalence Area of Northeastern Thailand: A 10-Year Large Scale Screening Program.
Anchalee N; Thinkhamrop K; Suwannatrai AT; Titapun A; Loilome W; Kelly M
Asian Pac J Cancer Prev; 2024 Feb; 25(2):537-546. PubMed ID: 38415540
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of cholangiocarcinoma: an update focusing on risk factors.
Shin HR; Oh JK; Masuyer E; Curado MP; Bouvard V; Fang YY; Wiangnon S; Sripa B; Hong ST
Cancer Sci; 2010 Mar; 101(3):579-85. PubMed ID: 20085587
[TBL] [Abstract][Full Text] [Related]
5. Modeling the persistence of Opisthorchis viverrini worm burden after mass-drug administration and education campaigns with systematic adherence.
Kamber L; Bürli C; Harbrecht H; Odermatt P; Sayasone S; Chitnis N
PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011362. PubMed ID: 38422118
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of the Urinary Metabolic Profile of Liver Fluke-Associated Cholangiocarcinoma.
Alsaleh M; Sithithaworn P; Khuntikeo N; Loilome W; Yongvanit P; Chamadol N; Hughes T; O'Connor T; Andrews RH; Holmes E; Taylor-Robinson SD
J Clin Exp Hepatol; 2019; 9(6):657-675. PubMed ID: 31889746
[TBL] [Abstract][Full Text] [Related]
7. Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem.
Hughes T; O'Connor T; Techasen A; Namwat N; Loilome W; Andrews RH; Khuntikeo N; Yongvanit P; Sithithaworn P; Taylor-Robinson SD
Int J Gen Med; 2017; 10():227-237. PubMed ID: 28848361
[TBL] [Abstract][Full Text] [Related]
8. Associations of Liver Fluke Infection and Cholangiocarcinoma: A Scoping Review.
Sivanand A; Talati D; Kalariya Y; Patel P; Gandhi SK
Cureus; 2023 Oct; 15(10):e46400. PubMed ID: 37927641
[TBL] [Abstract][Full Text] [Related]
9. Pesticide exposure and risk of cholangiocarcinoma: A hospital-based matched case-control study.
Pugkhem A; Kamsa-Ard S; Kamsa-Ard S; Luvira V; Luvira V; Bhudhisawasdi V
Trop Med Int Health; 2024 May; 29(5):390-404. PubMed ID: 38481371
[TBL] [Abstract][Full Text] [Related]
10. Teleconsultation ultrasonography: a new weapon to combat cholangiocarcinoma.
Chamadol N; Laopaiboon V; Srinakarin J; Loilome W; Yongvanit P; Thinkhamrop B; Khuntikeo N
ESMO Open; 2017; 2(3):e000231. PubMed ID: 29209530
[TBL] [Abstract][Full Text] [Related]
11. Cholangiocarcinoma 2020: the next horizon in mechanisms and management.
Banales JM; Marin JJG; Lamarca A; Rodrigues PM; Khan SA; Roberts LR; Cardinale V; Carpino G; Andersen JB; Braconi C; Calvisi DF; Perugorria MJ; Fabris L; Boulter L; Macias RIR; Gaudio E; Alvaro D; Gradilone SA; Strazzabosco M; Marzioni M; Coulouarn C; Fouassier L; Raggi C; Invernizzi P; Mertens JC; Moncsek A; Ilyas SI; Heimbach J; Koerkamp BG; Bruix J; Forner A; Bridgewater J; Valle JW; Gores GJ
Nat Rev Gastroenterol Hepatol; 2020 Sep; 17(9):557-588. PubMed ID: 32606456
[TBL] [Abstract][Full Text] [Related]
12. Urinary Metabolic Profiling of Liver Fluke-Induced Cholangiocarcinoma-A Follow-Up Study.
Alsaleh M; Sithithaworn P; Khuntikeo N; Loilome W; Yongvanit P; Hughes T; O'Connor T; Andrews RH; Wadsworth CA; Williams R; Koomson L; Cox IJ; Holmes E; Taylor-Robinson SD
J Clin Exp Hepatol; 2023; 13(2):203-217. PubMed ID: 36950498
[TBL] [Abstract][Full Text] [Related]
13. Development of Fruit and Vegetable Consumption Promotion Model in a High-Risk Population for Cholangiocarcinoma in Thailand: An Action Research.
Suriyut P; Songserm N; Raksilp M
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3029-3036. PubMed ID: 37774054
[TBL] [Abstract][Full Text] [Related]
14. Update on the Screening, Diagnosis, and Management of Cholangiocarcinoma.
Kodali S; Connor AA; Brombosz EW; Ghobrial RM
Gastroenterol Hepatol (N Y); 2024 Mar; 20(3):151-158. PubMed ID: 38680168
[TBL] [Abstract][Full Text] [Related]
15. Cohort study to assess geographical variation in cholangiocarcinoma treatment in England.
Jose S; Zalin-Miller A; Knott C; Paley L; Tataru D; Morement H; Toledano MB; Khan SA
World J Gastrointest Oncol; 2023 Dec; 15(12):2077-2092. PubMed ID: 38173436
[TBL] [Abstract][Full Text] [Related]
16. The importance of preclinical models in cholangiocarcinoma.
McGreevy O; Bosakhar M; Gilbert T; Quinn M; Fenwick S; Malik H; Goldring C; Randle L
Eur J Surg Oncol; 2024 Mar; ():108304. PubMed ID: 38653585
[TBL] [Abstract][Full Text] [Related]
17. Synopsis.
Khuntikeo N; Andrews RH; Petney TN; Khan SA
Recent Results Cancer Res; 2023; 219():361-367. PubMed ID: 37660340
[TBL] [Abstract][Full Text] [Related]
18. [Control of Opisthorchis viverrini infection for cholangiocarcinoma prevention].
Buisson Y
Bull Soc Pathol Exot; 2017 Feb; 110(1):61-67. PubMed ID: 28105582
[TBL] [Abstract][Full Text] [Related]
19. Current status of human liver fluke infections in the Greater Mekong Subregion.
Sripa B; Suwannatrai AT; Sayasone S; Do DT; Khieu V; Yang Y
Acta Trop; 2021 Dec; 224():106133. PubMed ID: 34509453
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
